Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor
- PMID: 3083507
- DOI: 10.1126/science.3083507
Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor
Abstract
Monocytes are a subpopulation of peripheral blood leukocytes, which when appropriately activated by the regulatory hormones of the immune system, are capable of becoming macrophages--potent effector cells for immune response to tumors and parasites. A complementary DNA for the T lymphocyte-derived lymphokine, granulocyte-macrophage colony-stimulating factor (GM-CSF), has been cloned, and recombinant GM-CSF protein has been expressed in yeast and purified to homogeneity. This purified human recombinant GM-CSF stimulated peripheral blood monocytes in vitro to become cytotoxic for the malignant melanoma cell line A375. Another T cell-derived lymphokine, gamma-interferon (IFN-gamma), also stimulated peripheral blood monocytes to become tumoricidal against this malignant cell line. When IFN-gamma activates monocytes to become tumoricidal, additional stimulation by exogenously added lipopolysaccharide is required. No such exogenous signals were required for the activation of monocytes by GM-CSF.
Similar articles
-
Differential effect of recombinant granulocyte macrophage colony-stimulating factor on human monocytes and alveolar macrophages.Cancer Res. 1989 Aug 1;49(15):4086-9. Cancer Res. 1989. PMID: 2545332
-
Bone marrow progenitors cultured in the presence of granulocyte-macrophage colony-stimulating factor versus macrophage colony-stimulating factor differentiate into macrophages with distinct tumoricidal capacities.J Leukoc Biol. 1988 May;43(5):471-6. doi: 10.1002/jlb.43.5.471. J Leukoc Biol. 1988. PMID: 3131473
-
Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.J Immunol. 1988 Nov 15;141(10):3680-6. J Immunol. 1988. PMID: 3053901
-
A potential role of macrophage activation in the treatment of cancer.Crit Rev Oncol Hematol. 2002 Nov;44(2):143-61. doi: 10.1016/s1040-8428(01)00203-7. Crit Rev Oncol Hematol. 2002. PMID: 12413632 Review.
-
Molecular properties and biological activity of human macrophage growth factor, CSF-1.Haematol Blood Transfus. 1987;31:221-7. doi: 10.1007/978-3-642-72624-8_46. Haematol Blood Transfus. 1987. PMID: 3327772 Review. No abstract available.
Cited by
-
Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: analysis by cytokine secretion.Cancer Immunol Immunother. 1993;36(1):1-8. doi: 10.1007/BF01789124. Cancer Immunol Immunother. 1993. PMID: 8422663 Free PMC article.
-
Cutaneous side effects in breast cancer patients treated with cytostatic polychemotherapy and rh GM-CSF: immune phenomena or drug toxicity?Breast Cancer Res Treat. 1995 Jun;34(3):213-9. doi: 10.1007/BF00689712. Breast Cancer Res Treat. 1995. PMID: 7579485 Clinical Trial.
-
Granulocyte-macrophage colony-stimulating factor (GM-CSF) counteracts the inhibiting effect of monocytes on natural killer (NK) cells.Clin Exp Immunol. 1995 Sep;101(3):515-20. doi: 10.1111/j.1365-2249.1995.tb03143.x. Clin Exp Immunol. 1995. PMID: 7664499 Free PMC article.
-
Macrophages and dendritic cells as actors in the immune reaction of classical Hodgkin lymphoma.PLoS One. 2014 Dec 3;9(12):e114345. doi: 10.1371/journal.pone.0114345. eCollection 2014. PLoS One. 2014. PMID: 25470820 Free PMC article.
-
Effects of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha on Trypanosoma cruzi trypomastigotes.Infect Immun. 1998 Jun;66(6):2722-7. doi: 10.1128/IAI.66.6.2722-2727.1998. Infect Immun. 1998. PMID: 9596739 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases